Hamilton Thorne Ltd (CVE:HTL) Director Robert J. Potter sold 21,300 shares of the stock in a transaction on Friday, January 10th. The stock was sold at an average price of C$1.10, for a total transaction of C$23,430.00. Following the sale, the director now directly owns 57,843 shares in the company, valued at C$63,627.30.
Hamilton Thorne stock opened at C$1.15 on Thursday. The company has a 50-day simple moving average of C$1.06 and a 200-day simple moving average of C$1.06. The firm has a market capitalization of $144.07 million and a P/E ratio of 52.27. The company has a debt-to-equity ratio of 35.96, a quick ratio of 1.38 and a current ratio of 1.98. Hamilton Thorne Ltd has a one year low of C$0.86 and a one year high of C$1.25.
About Hamilton Thorne
Hamilton Thorne Ltd., together with its subsidiary, Hamilton Thorne, Inc, develops, manufactures, and sells precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets. The company offers clinical lasers, such as LYKOS and ZILOS-tk lasers, as well as clinical laser software and hardware for clinical assisted reproduction; and research lasers, including XYRCOS and XYClone lasers for stem cell research, gene targeting, knock out mouse production, SCNT, ICSI, IVF, and assisted hatching applications, as well as Stiletto lasers for isolation of cells of interest, ablation of unwanted cells, and precision scoring of cell colonies.
Featured Article: Overbought
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.